Sarepta Therapeutics, Inc.
Healthcare · Biotechnology · $1.85B market cap · Ranked #915 of 1,201
Scores well below the universe median on the composite. Ranks in the 24th percentile overall.
Nothing notable on this side.
Figures come straight from the company’s filed quarterly report and feed the six-factor model (growth, quality, and value especially). This is a summary of what was reported — research, not a recommendation, and there are no analyst estimates behind it, so it isn’t a beat-or-miss call.
The latest raw values feeding the six factors.
Every rating we’ve ever assigned SRPT — append-only and hash-verified. We don’t revise or delete past calls.
2 rating changes across 37 snapshots — each with the factor shift that drove it.
The full append-only record of every call we’ve made on SRPT— the accountability history mainstream sites quietly edit and we can’t — is part of Proofstock Plus.
Unlock with Plus